Selcita Tablet 50 mg (Sitagliptin Hydrochloride Hydrate)

Adult dose

This medication is administered once daily at a dose of 100 mg for monotherapy or combination therapy; the maximum daily dose is 100 mg. It can be taken regardless of meals. In patients with renal impairment, dose adjustments are necessary based on renal function. - Mild renal impairment (glomerular filtration rate 60 to <90): No dose adjustment necessary - Moderate renal impairment (glomerular filtration rate 45 to <60): No dose adjustment necessary - Moderate renal impairment (glomerular filtration rate ...

This medication is used for diabetes treatment, and severe allergic reactions may occur during use, requiring caution. If symptoms of hypersensitivity such as skin rash, angioedema, or difficulty breathing occur within 3 months of starting the medication, it should be discontinued immediately and a doctor should be consulted. Additionally, serious side effects including acute pancreatitis have been reported; therefore, if symptoms such as abdominal pain, nausea, or vomiting occur during use, medical personnel should be notified immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and should not be administered if there is an allergy to the drug or its components. Patients with impaired renal function may have difficulty excreting the medication, requiring dose adjustments, and it is recommended to have regular kidney function tests. Hypoglycemic symptoms may occur during treatment, especially when used in conjunction with insulin or sulfonylureas, increasing the risk, so blood sugar levels should be monitored closely. Furthermore, severe joint pain or skin blistering may occur after medication administration; if such symptoms are present, the physician should be notified immediately. Women who are pregnant or breastfeeding are advised not to use this medication due to uncertain safety. Elderly patients may have reduced kidney function, necessitating dose adjustments and kidney function tests. In case of overdose, general emergency treatment should be administered, and some of the drug may be removed via hemodialysis if necessary. This medication may increase the risk of hypoglycemia when used in combination with other hypoglycemic agents, so dose adjustment may be necessary when combined. Drug interactions are relatively rare; however, it is advisable to consult a doctor when taking certain medications. If there are any unusual symptoms or suspected side effects during use, immediate consultation with medical personnel is required.

Serious side effects

Hives, angioedema, anaphylaxis, exfoliative skin diseases such as Stevens-Johnson syndrome, acute pancreatitis, acute renal failure, severe joint pain with disabilities, blistering similar to pemphigus, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest

Mild side effects

• Upper respiratory tract infection
• nasopharyngitis
• headache
• constipation
• vomiting
• muscle pain
• limb pain
• back pain
• pruritus
• diarrhea

Store this medication in a tightly closed container to prevent air or moisture ingress, and keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness and safety of the drug.

Appearance

Light orange, round, biconvex film-coated tablet

Package unit

28 tablets (14 tablets/PTP x 2) - 14 tablets/PTP [28 tablets (14 tablets/PTP x 2)], 30 tablets (10 tablets/PTP x 3) - 10 tablets/PTP [30 tablets (10 tablets/PTP x 3)]